Guggenheim Capital LLC Palatin Technologies Inc Transaction History

Guggenheim Capital LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$0.91 - $1.45 $39,474 - $62,899	-43,379 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$0.84 - $1.18 $221 - $311	264 Added 0.61%	43,379 $47,000
Q4 2017 Feb 14, 2018	BUY	$0.68 - $1.0 $29,318 - $43,115	43,115	43,115 $37,000

3.02K

Ticker PTN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,290,480
Market Cap $13.2M
Description
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing o...

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Guggenheim Capital LLC with notifications on news.